Gray Nancy Ryan bought LGND
June 14, 2024 · Form 4 insider transaction
Gray Nancy Ryan bought 1,252 shares of Ligand Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,252
Price
$0.00
Total value
N/A
InsiderGray Nancy Ryan
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 14, 2024
Filing dateJune 18, 2024
Shares owned after6,885
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.